We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Biotechs are taking notice as a new pool of funding is being made available by venture capital Andreesen Horowitz. This is the second fund from the VC that is aimed at life sciences. In 2015, the firm established a fund with $200 million for investments.